Further analysis of the restoration of CD4+ and CD8+ T cells in granulomas of the 2 treatment groups demonstrated a significantly higher (P < 0.0001) restoration of CD4+ T cells (Supplemental Figure 3E) and a lower percentage of CD8+ T cells (Supplemental Figure 3F) in the cART/2-week compared with the cART/4-week group. The gene discussed is CD4; the disease is Granuloma.